News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TiGenix Completes EUR 12 Million Capital Increase With Strategic Investor Grifols


11/22/2013 9:28:33 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEUVEN, Belgium, Nov. 22, 2013 (GLOBE NEWSWIRE) -- TiGenix NV (Brussels:TIG) announced today the successful completion of the EUR 12 million capital increase announced on November 20, 2013. In total, 34.188.034 new ordinary shares were issued to Gri-Cel S.A., a fully-owned subsidiary of global healthcare company Grifols S.A. TiGenix will prepare and, after approval by the FSMA, publish a prospectus regarding the admittance of the new shares to trading on NYSE Euronext Brussels, which is expected to take place in the following weeks.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
TiGenix
Grifols
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES